FDA OKs Boehringer Ingelheim inhalation spray
Boehringer Ingelheim Pharmaceuticals Inc. scored an approval from the U.S. Food and Drug Administration for Combivent Respimat, its inhalation spray to treat patients with chronic obstructive pulmonary disease (COPD).

Cardium Announces Excellagen FDA 510(K) Clearance
Cardium Therapeutics (CXM) has received FDA 510(k) clearance to market and sell Excellagen(tm) professional-use advanced wound care product for diabetic foot ulcers, pressure ulcers and other dermal wounds.

Study Finds Consumers Unclear on FDA Drug Approvals
Navigating the world of prescription drugs can be confusing, and a new study confirms that American consumers are not clear about the safety of approved drugs. The Report appears in the Archives of Internal Medicine. Reuters Health wrote that, for the most part, consumers believe drugs approved by the U.S. Food and Drug Administration (FDA) are [...]